Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4381273 | 0.94 | MAPK14 (0.62) | MAPK14PTGER1 | |
| SCHEMBL6501116 | 0.91 | MAPK14 (0.71) | MAPK14PTGER1 | |
| SCHEMBL6502062 | 0.89 | MAPK14 (0.76) | MAPK14PTGER1 | |
| SCHEMBL28466146 | 0.89 | MAPK14 (0.63) | MAPK14PTGER1 | |
| SCHEMBL29593495 | 0.87 | MAPK14 (0.81) | MAPK14PTGER1 | |
| SCHEMBL4379147 | 0.87 | MAPK14 (0.81) | MAPK14PTGER1 | |
| SCHEMBL6472051 | 0.84 | MAPK14 (0.76) | MAPK14PTGER1 | |
| SCHEMBL6524828 | 0.80 | MAPK14 (0.59) | MAPK14 | |
| SCHEMBL6473354 | 0.80 | MAPK14 (0.78) | MAPK14PTGER1 | |
| SCHEMBL29593593 | 0.80 | MAPK14 (0.69) | MAPK14PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050176775-A1 | Substituted pyridinones | PHARMACIA CORPORATION | 2005-08-11 | — | — | US | claimed |
| US-20050176775-A1 | Substituted pyridinones | PHARMACIA CORPORATION | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176775-A1 | Substituted pyridinones | MAPK1, MAPK6, MAP3K6 | MAPK14 53/4885PTGER1 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.